Identification of Drug-resistance Core Genes and Drug Targets in Lung Adenocarcinoma Patients Harboring ALK Fusion Gene

Identification of Drug-resistance Core Genes and Drug Targets in Lung Adenocarcinoma Patients Harboring ALK Fusion Gene

Objective To compare DEGs between primary and metastatic lesions in lung adenocarcinoma patients with positive ALK fusion gene, and to explore the mechanism of drug-resistance and the potential drug targets in metastatic lesions of lung adenocarcinoma patients. Methods GSE125864 was obtained from GE...

Full description

Bibliographic Details
Main Authors: QI Chunyan, WU Tao, QI Xiaoguang
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2021-05-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
lung adenocarcinoma
positive alk fusion gene
bioinformatics
heterogeneity
drug targets
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2021.20.1206.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2021.20.1206.htm

Similar Items